Skip to main content
HR 5160 119th Congress House Health Biological and life sciences Blood and blood diseases Cell biology and embryology Health programs administration and funding Organ and tissue donation and transplantation

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Introduced: April 2, 2026 Introduced by: Smith, Christopher H. Republican · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 2, 2026
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Jul 2, 2026
Placed on the Union Calendar, Calendar No. 629.
May 21, 2026
Committee Consideration and Mark-up Session Held
May 21, 2026
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
May 13, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026
Subcommittee Consideration and Mark-up Session Held
Sep 4, 2025
Referred to the Subcommittee on Health.
Sep 4, 2025
Introduced in House
Sep 4, 2025
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 2, 2026

Placed on the Union Calendar, Calendar No. 629.

 Hearings & markups 1
 Related & companion bills 1
  • S 4109 Related bill Stem Cell Therapeutic and Research Reauthorization Act of 2026
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 14

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 14 filings →
 Cosponsors 21
All 21 Democratic 11 Republican 10
D
Davids, Sharice
Kansas · May 29, 2026
 R
Fitzpatrick, Brian K.
Pennsylvania · May 29, 2026
 R
Lawler, Michael
New York · May 21, 2026
 D
Vindman, Eugene Simon
Virginia · May 21, 2026
 R
Finstad, Brad
Minnesota · Apr 30, 2026
 D
Morrison, Kelly
Minnesota · Apr 30, 2026
 D
Barragán, Nanette Diaz
California · Apr 27, 2026
 R
Bentz, Cliff
Oregon · Apr 27, 2026
 D
Castor, Kathy
Florida · Apr 2, 2026
 R
Garbarino, Andrew R.
New York · Apr 2, 2026
 R
Malliotakis, Nicole
New York · Apr 2, 2026
 D
Norton, Eleanor Holmes
District of Columbia · Apr 2, 2026
 R
Aderholt, Robert B.
Alabama · Feb 10, 2026
 D
Gottheimer, Josh
New Jersey · Feb 10, 2026
 D
Dingell, Debbie
Michigan · Feb 4, 2026
 R
Fischbach, Michelle
Minnesota · Feb 4, 2026
 R
Bilirakis, Gus M.
Florida · Sep 4, 2025
 D
Matsui, Doris O.
California · Sep 4, 2025
 D
Mfume, Kweisi
Maryland · Sep 4, 2025
 D
Pingree, Chellie
Maine · Sep 4, 2025
 R
Tenney, Claudia
New York · Sep 4, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-5160/
MLA
"H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-5160/.
Bluebook (legal)
H.R. 5160, 119th Cong. (2026), https://openamerica.io/bill/119-HR-5160/.
Markdown link
[H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025](https://openamerica.io/bill/119-HR-5160/)
Report a problem